The Complete Guide to MOTS-c Research
Research Guide
The Complete Guide to MOTS-c Research
MOTS-c is a mitochondrially-encoded 16-residue peptide that activates AMPK. Mechanism, animal findings, and comparison with SS-31.
Read MoreThe Complete Guide to BPC-157 Research
Research Guide
The Complete Guide to BPC-157 Research
BPC-157 is a 15-residue synthetic peptide with 200+ preclinical publications on tissue repair and GI integrity. Mechanism and handling.
Read MoreThe Essential Guide to 5-Amino-1MQ Research in 2026
Research Guide
The Essential Guide to 5-Amino-1MQ Research in 2026
5-Amino-1MQ inhibits NNMT — a metabolic brake on the NAD+ salvage pathway. Mechanism, animal data, and purity considerations.
Read MoreThe Complete Guide to NAD+ Research in 2026
Research Guide
The Complete Guide to NAD+ Research in 2026
NAD+, NMN, NR — precursor pathways, sirtuin activation, handling considerations, and what purity documentation to demand.
Read MoreThe Complete Guide to SS-31 (Elamipretide) Research
Research Guide
The Complete Guide to SS-31 (Elamipretide) Research
SS-31 is a mitochondria-targeted tetrapeptide that binds cardiolipin. Structure, MMPOWER trial data, and purity considerations for research.
Read MoreCagriSema vs Retatrutide: Research Comparison
Research Guide
CagriSema vs Retatrutide: Research Comparison
Two-peptide combination vs single triple-agonist. Efficacy magnitude, mechanism, adverse events, and how to evaluate purity for both.
Read MoreThe Complete Guide to CagriSema Research
Research GuideThe Complete Guide to CagriSema Research
CagriSema combines cagrilintide (amylin analog) with semaglutide (GLP-1). REDEFINE Phase 3 data, mechanism, and handling for research.
Read MoreTirzepatide vs Semaglutide: Complete Research Comparison
Research Guide
Tirzepatide vs Semaglutide: Complete Research Comparison
SURPASS-2 head-to-head data, receptor pharmacology, dosing schedules, and where retatrutide fits in the incretin research landscape.
Read MoreThe Complete Guide to Retatrutide Research in 2026
Research Guide
The Complete Guide to Retatrutide Research in 2026
Retatrutide (LY-3437943) is a GLP-1 / GIP / glucagon triple agonist. Mechanism, Phase 2 data, handling, and purity considerations for research.
Read More